Ursula A. Germann
Impact in
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
-
- Adenosine and Purinergic Signaling 6
- Oncology 27
- Drug Transport and Resistance Mechanisms 26
- Co-authors
- Michael M. GottesmanIra PastanBalázs SarkadiElmer M. PriceChristine A. HrycynaR. C. BoucherKonrad LerchGene A. Scarborough
- Journals
- Journal of Biological Chemistry (8 papers)Biochemistry (4 papers)Anti-Cancer Drugs (2 papers)The FASEB Journal (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesSwitzerlandHungary
In The Last Decade
Ursula A. Germann
49 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 2.9k
- Pediatrics, Perinatology and Child Health 935
- Infectious Diseases 791
- Physiology 176
- Molecular Biology 2.4k
Countries citing papers authored by Ursula A. Germann
This map shows the geographic impact of Ursula A. Germann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula A. Germann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula A. Germann more than expected).
Fields of papers citing papers by Ursula A. Germann
This network shows the impact of papers produced by Ursula A. Germann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula A. Germann. The network helps show where Ursula A. Germann may publish in the future.
Co-authors
The 25 scholars most cited alongside Ursula A. Germann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 250 | |
| 2 | 2005 | 106 | |
| 3 | 2003 | 1 | |
| 4 | 2000 | 6 | |
| 5 | 1999 | 71 | |
| 6 | 1998 | 14 | |
| 7 | 1997 | 119 | |
| 8 | 1997 | 113 | |
| 9 | 1996 | 149 | |
| 10 | 1996 | 368 | |
| 11 | 1995 | 57 | |
| 12 | 1995 | 16 | |
| 13 | 1995 | 417 | |
| 14 | 1995 | 41 | |
| 15 | 1994 | 6 | |
| 16 | 1994 | 27 | |
| 17 | 1991 | 17 | |
| 18 | 1991 | 32 | |
| 19 | 1990 | 110 | |
| 20 | 1987 | 11 |
About Ursula A. Germann
Ursula A. Germann is a scholar working on Physiology, Oncology, Biochemistry, Infectious Diseases and Molecular Biology, having authored 49 papers that have together received 4.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (26 papers), HIV/AIDS drug development and treatment (10 papers), Melanoma and MAPK Pathways (6 papers), Adenosine and Purinergic Signaling (6 papers), Amino Acid Enzymes and Metabolism (5 papers), Enzyme-mediated dye degradation (4 papers), RNA Interference and Gene Delivery (4 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Oncology (2.9k citations), Pediatrics, Perinatology and Child Health (935 citations), Infectious Diseases (791 citations), Physiology (176 citations) and Molecular Biology (2.4k citations). Ursula A. Germann has collaborated with scholars based in United States, Switzerland and Hungary. Frequent co-authors include Michael M. Gottesman, Ira Pastan, Balázs Sarkadi, Elmer M. Price, Christine A. Hrycyna, R. C. Boucher, Konrad Lerch, Gene A. Scarborough, I Pastan and Patricia V. Schoenlein. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Anti-Cancer Drugs, The FASEB Journal and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.